{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:58:19Z","timestamp":1791849499091,"version":"4.3.4"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD06\/0016\/1013"],"award-info":[{"award-number":["RD06\/0016\/1013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0021\/0023"],"award-info":[{"award-number":["RD12\/0021\/0023"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0009\/0017"],"award-info":[{"award-number":["RD16\/0009\/0017"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0005\/0001"],"award-info":[{"award-number":["RD21\/0005\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0005\/0013"],"award-info":[{"award-number":["RD21\/0005\/0013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD21\/0005\/0019"],"award-info":[{"award-number":["RD21\/0005\/0019"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ICI14\/00107"],"award-info":[{"award-number":["ICI14\/00107"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00384"],"award-info":[{"award-number":["PI17\/00384"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00633"],"award-info":[{"award-number":["PI20\/00633"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["GRUPIN14-028"],"award-info":[{"award-number":["GRUPIN14-028"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["IDI-2018-000152"],"award-info":[{"award-number":["IDI-2018-000152"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["IDI\/2021\/000080"],"award-info":[{"award-number":["IDI\/2021\/000080"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011941","name":"Gobierno del Principado de Asturias","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,31]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Diabetic patients on haemodialysis have a higher risk of mortality than non-diabetic patients. The aim of this COSMOS (Current management of secondary hyperparathyroidism: a multicentre observational study) analysis was to assess whether bone and mineral laboratory values [calcium, phosphorus and parathyroid hormone (PTH)] contribute to this risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>COSMOS is a multicentre, open-cohort, 3-year prospective study, which includes 6797 patients from 227 randomly selected dialysis centres in 20 European countries. The association between mortality and calcium, phosphate or PTH was assessed using Cox proportional hazard regression models using both penalized splines smoothing and categorization according to KDIGO guidelines. The effect modification of the association between the relative risk of mortality and serum calcium, phosphate or PTH by diabetes was assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There was a statistically significant effect modification of the association between the relative risk of mortality and serum PTH by diabetes (P\u00a0=\u00a0.011). The slope of the curve of the association between increasing values of PTH and relative risk of mortality was steeper for diabetic compared with non-diabetic patients, mainly for high levels of PTH. In addition, high serum PTH (&amp;gt;9 times the normal values) was significantly associated with a higher relative risk of mortality in diabetic patients but not in non-diabetic patients [1.53 (95% confidence interval 1.07\u20132.19) and 1.17 (95% confidence interval 0.91\u20131.52)]. No significant effect modification of the association between the relative risk of mortality and serum calcium or phosphate by diabetes was found (P\u00a0=\u00a0.2 and P\u00a0=\u00a0.059, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The results show a different association of PTH with the relative risk of mortality in diabetic and non-diabetic patients. These findings could have relevant implications for the diagnosis and treatment of chronic kidney disease\u2013mineral and bone disorders.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfad122","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T19:47:55Z","timestamp":1687636075000},"page":"2589-2597","source":"Crossref","is-referenced-by-count":14,"title":["Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1683-6617","authenticated-orcid":false,"given":"Beatriz","family":"Mart\u00edn-Carro","sequence":"first","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA), Bone and Mineral Research Unit, REDinREN and RICORS2040 del ISCIII , Oviedo , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5015-7474","authenticated-orcid":false,"given":"Juan F","family":"Navarro-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n y Servicio de Nefrolog\u00eda, Hospital Universitario Nuestra Se\u00f1ora de Candelaria , Santa Cruz de Tenerife , Spain"},{"name":"RICORS2040 (RD21\/0005\/0013), Instituto de Salud Carlos III , Madrid , Spain"},{"name":"GEENDIAB, Sociedad Espa\u00f1ola de Nefrolog\u00eda , Santander , Spain"},{"name":"Instituto de Tecnolog\u00edas Biom\u00e9dicas, Universidad de La Laguna , Santa Cruz de Tenerife , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-9523","authenticated-orcid":false,"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, IIS-Fundaci\u00f3n Jimenez Diaz UAM , Madrid , Spain"},{"name":"RICORS2040 , Madrid , Spain"},{"name":"Departamento de Medicina, Facultad de Medicina, Universidad Aut\u00f3noma de Madrid , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1996","authenticated-orcid":false,"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[{"name":"Renal Research Institute , New York , USA"},{"name":"Institute of Molecular Biology and Genetics (Biogem) , Ariano Irpino , Italy"},{"name":"Associazione Ipertensione Nefrologia Trapianto Renal (IPNET), c\/o Nefrolog\u00eda, Grande Ospedale Metropolitano , Reggio Calabria , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[{"name":"RWTH Aachen University, Div. Nephrology , Aachen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel A","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Nova Medical School-Vice Dean , Lisboa , Portugal"},{"name":"Centro Hospitalar Universit\u00e1rio de Lisboa Central \u2013 Hospital Curry Cabral, Nephrology Department , Lisboa , Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1134-9051","authenticated-orcid":false,"given":"Jos\u00e9 L","family":"Gorriz-Teruel","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Cl\u00ednico Universitario , Valencia , Spain"},{"name":"Department of Medicine, Health Research Institute INCLIVA, University of Valencia , Valencia , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Carrillo-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA), Bone and Mineral Research Unit, REDinREN and RICORS2040 del ISCIII , Oviedo , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Panizo","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA), Bone and Mineral Research Unit, REDinREN and RICORS2040 del ISCIII , Oviedo , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7505-261X","authenticated-orcid":false,"given":"Francesco","family":"Locatelli","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Alessandro Manzoni Hospital (past director) , Lecco , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ketteler","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine and Nephrology, Robert-Bosch-Krankenhaus GmbH , Stuttgart , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard M","family":"London","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier FH , Manhes , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Naves-D\u00edaz","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA), Bone and Mineral Research Unit, REDinREN and RICORS2040 del ISCIII , Oviedo , Spain"},{"name":"Hospital Universitario Central de Asturias, Bone and Mineral Research Unit, REDinREN and RICORS2040 del ISCIII, Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA) , Oviedo , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Alonso-Montes","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA), Bone and Mineral Research Unit, REDinREN and RICORS2040 del ISCIII , Oviedo , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge B","family":"Cannata-And\u00eda","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA), Bone and Mineral Research Unit, REDinREN and RICORS2040 del ISCIII , Oviedo , Spain"},{"name":"Hospital Universitario Central de Asturias, Bone and Mineral Research Unit, REDinREN and RICORS2040 del ISCIII, Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA) , Oviedo , Spain"},{"name":"Department of Medicine, Universidad de Oviedo , Oviedo , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L","family":"Fern\u00e1ndez-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA), Bone and Mineral Research Unit, REDinREN and RICORS2040 del ISCIII , Oviedo , Spain"},{"name":"Hospital Universitario Central de Asturias, Bone and Mineral Research Unit, REDinREN and RICORS2040 del ISCIII, Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA) , Oviedo , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"2023103100561715500_bib1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet North Am Ed"},{"key":"2023103100561715500_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ndt\/gfaa195","article-title":"The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation","volume":"36","author":"Tabibzadeh","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2147\/IJNRD.S340028","article-title":"Effect of citrate-acidified dialysate on intact parathyroid hormone in prevalent hemodialysis patients: a matched retrospective cohort study","volume":"14","author":"Ficociello","year":"2021","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"2023103100561715500_bib4","first-page":"59","article-title":"Cardiovascular disease in dialysis patients","volume-title":"Aspects in Dialysis","author":"Jegatheesan","year":"2017"},{"key":"2023103100561715500_bib5","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"2023103100561715500_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00223-020-00777-1","article-title":"Chronic kidney disease-mineral and bone disorders: pathogenesis and management","volume":"108","author":"Cannata-Andia","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"2023103100561715500_bib7","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2023103100561715500_bib8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"2023103100561715500_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"2023103100561715500_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2008.05.020","article-title":"Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study","volume":"52","author":"Wald","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"2023103100561715500_bib11","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","article-title":"Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study","volume":"26","author":"Naves-Diaz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib12","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ndt\/gfs404","article-title":"Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?","volume":"28","author":"Fouque","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib14","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","article-title":"Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study","volume":"30","author":"Fernandez-Martin","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"key":"2023103100561715500_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11914-015-0270-3","article-title":"Molecular mechanisms of vascular calcification in chronic kidney disease: the link between bone and the vasculature","volume":"13","author":"Byon","year":"2015","journal-title":"Curr Osteoporos Rep"},{"key":"2023103100561715500_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2017.02.095","article-title":"Risk factors for mortality in patients undergoing hemodialysis: a systematic review and meta-analysis","volume":"238","author":"Ma","year":"2017","journal-title":"Int J Cardiol"},{"key":"2023103100561715500_bib18","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1093\/ndt\/gfi039","article-title":"Aortic calcification in haemodialysis patients with diabetes mellitus","volume":"20","author":"Taniwaki","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1523-1755.2003.00068.x","article-title":"Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease","volume":"64","author":"Merjanian","year":"2003","journal-title":"Kidney Int"},{"key":"2023103100561715500_bib20","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1093\/ndt\/gfm377","article-title":"Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes","volume":"22","author":"Porter","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib21","first-page":"181","article-title":"Vascular calcification of the aortic arch and peripheral artery in haemodialysis patients with and without diabetes mellitus","volume":"40","author":"Sutandar","year":"2008","journal-title":"Acta Med Indones"},{"key":"2023103100561715500_bib22","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1007\/s00125-002-0920-8","article-title":"Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients\u2014importance of glycaemic control","volume":"45","author":"Ishimura","year":"2002","journal-title":"Diabetologia"},{"key":"2023103100561715500_bib23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jama.1981.03310340020020","article-title":"Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis","volume":"245","author":"Vincenti","year":"1981","journal-title":"JAMA"},{"key":"2023103100561715500_bib24","first-page":"290","article-title":"Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS)","volume":"21","author":"Cannata-Andia","year":"2008","journal-title":"J Nephrol"},{"key":"2023103100561715500_bib25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ki.2013.185","article-title":"Use of phosphate-binding agents is associated with a lower risk of mortality","volume":"84","author":"Cannata-Andia","year":"2013","journal-title":"Kidney Int"},{"key":"2023103100561715500_bib26","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/ndt\/gfs418","article-title":"COSMOS: the dialysis scenario of CKD-MBD in Europe","volume":"28","author":"Fernandez-Martin","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ndt\/gfy093","article-title":"Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study","volume":"34","author":"Fernandez-Martin","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"2023103100561715500_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ndt\/gfm639","article-title":"Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy","volume":"23","author":"Murakami","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.diabres.2014.04.002","article-title":"Effect of glycemic control on intact parathyroid hormone level in end stage renal disease patients on maintenance hemodialysis","volume":"105","author":"Dan","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"2023103100561715500_bib31","first-page":"221","article-title":"Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis","volume":"19","author":"Pabico","year":"1983","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"2023103100561715500_bib32","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1172\/JCI106379","article-title":"Evidence for suppression of parathyroid gland activity by hypermagnesemia","volume":"49","author":"Massry","year":"1970","journal-title":"J Clin Invest"},{"key":"2023103100561715500_bib33","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1172\/JCI108582","article-title":"Inhibitory effects of hypermagnesemia on the renal action of parathyroid hormone","volume":"58","author":"Slatopolsky","year":"1976","journal-title":"J Clin Invest"},{"key":"2023103100561715500_bib34","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1172\/JCI107297","article-title":"The hormonal regulation of pyloric sphincter function","volume":"52","author":"Fisher","year":"1973","journal-title":"J Clin Invest"},{"key":"2023103100561715500_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000493278","article-title":"Inflammation in diabetic kidney disease","volume":"143","author":"P\u00e9rez-Morales","year":"2019","journal-title":"Nephron"},{"key":"2023103100561715500_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2023103100561715500_bib37","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"2023103100561715500_bib38","doi-asserted-by":"crossref","first-page":"121148","DOI":"10.1016\/j.lfs.2022.121148","article-title":"Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications","volume":"311","author":"Kaur","year":"2022","journal-title":"Life Sci"},{"key":"2023103100561715500_bib39","doi-asserted-by":"crossref","first-page":"115699","DOI":"10.1016\/j.bone.2020.115699","article-title":"Vascular calcification relationship to vascular biomarkers and bone metabolism in advanced chronic kidney disease","volume":"143","author":"Salam","year":"2021","journal-title":"Bone"},{"key":"2023103100561715500_bib40","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.3390\/ijms23073776","article-title":"Parathyroid hormone induces human valvular endothelial cells dysfunction that impacts the osteogenic phenotype of valvular interstitial cells","volume":"23","author":"Vadana","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2023103100561715500_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40618-021-01645-x","article-title":"Cardiac structural and functional abnormalities in primary hyperparathyroidism","volume":"45","author":"Purra","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"2023103100561715500_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.14797\/mdcj-13-2-49","article-title":"The parathyroid gland and heart disease","volume":"13","author":"Brown","year":"2017","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"2023103100561715500_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4330\/wjc.v14.i4.239","article-title":"Global longitudinal strain is superior to ejection fraction for detecting myocardial dysfunction in end-stage renal disease with hyperparathyroidism","volume":"14","author":"Carrasco-Ruiz","year":"2022","journal-title":"World J Cardiol"},{"key":"2023103100561715500_bib44","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfz060","article-title":"Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort","volume":"35","author":"Lamina","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.34067\/KID.0000772020","article-title":"Parathyroid hormone serum levels and mortality among hemodialysis patients in the Gulf Cooperation Council countries: results from the DOPPS (2012-2018)","volume":"1","author":"Al Salmi","year":"2020","journal-title":"Kidney360"},{"key":"2023103100561715500_bib46","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s40620-020-00916-9","article-title":"Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: the PECERA study","volume":"34","author":"Molina","year":"2021","journal-title":"J Nephrol"},{"key":"2023103100561715500_bib47","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1093\/ndt\/gfm370","article-title":"Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?","volume":"22","author":"Coen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"2023103100561715500_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0021-9150(00)00529-3","article-title":"Additive impacts of diabetes and renal failure on carotid atherosclerosis","volume":"153","author":"Shoji","year":"2000","journal-title":"Atherosclerosis"},{"key":"2023103100561715500_bib49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"2023103100561715500_bib50","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"2023103100561715500_bib51","doi-asserted-by":"crossref","first-page":"34696","DOI":"10.1038\/srep34696","article-title":"Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes","volume":"6","author":"Hu","year":"2016","journal-title":"Sci Rep"},{"key":"2023103100561715500_bib52","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.1800160115","article-title":"Insulin suppresses the production of fibroblast growth factor 23 (FGF23)","volume":"115","author":"Bar","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023103100561715500_bib53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int"},{"key":"2023103100561715500_bib54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ki.2011.107","article-title":"Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo","volume":"80","author":"Lopez","year":"2011","journal-title":"Kidney Int"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfad122\/50820388\/gfad122.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/11\/2589\/52661005\/gfad122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/11\/2589\/52661005\/gfad122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:25:47Z","timestamp":1698733547000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/38\/11\/2589\/7205511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6,22]]},"published-print":{"date-parts":[[2023,10,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfad122","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,6,22]]}}}